Cardiovascular involvement in patients affected by acromegaly: An appraisal
- 1 September 2013
- journal article
- review article
- Published by Elsevier BV in International Journal of Cardiology
- Vol. 167 (5), 1712-1718
- https://doi.org/10.1016/j.ijcard.2012.11.109
Abstract
No abstract availableThis publication has 73 references indexed in Scilit:
- Increased oxidized low density lipoprotein associated with high ceruloplasmin activity in patients with active acromegalyClinical Endocrinology, 2010
- Medical Treatment of Acromegaly: Comorbidities and Their Reversibility by Somatostatin AnalogsNeuroendocrinology, 2006
- Late potentials and ventricular arrhythmias in acromegalyInternational Journal of Cardiology, 2005
- Acromegalic Patients Show the Presence of Hypertrophic Remodeling of Subcutaneous Small Resistance ArteriesHypertension, 2004
- Glucose homeostasis in acromegaly: effects of long‐acting somatostatin analogues treatmentClinical Endocrinology, 2003
- LDL physical properties, lipoprotein and Lp(a) levels in acromegalic patients. Effects of octreotide therapyAtherosclerosis, 2000
- Signaling Pathways for Cardiac Hypertrophy and FailureThe New England Journal of Medicine, 1999
- Insulin and Insulin-Like Growth Factor in Normal and Pathological Cardiovascular PhysiologyHypertension, 1997
- AcromegalyThe New England Journal of Medicine, 1990
- Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patientsAmerican Heart Journal, 1980